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Objective: It is well documented that plasma ammonia accumulates during exercise under
conditions of metabolic stress. Metabolic stress (when skeletal muscle ATP supply fails to meet
demand) occurs at low work rates during cycling in patients with COPD, but not been described
during walking. Walking is an important activity for many patients with COPD and is commonly
prescribed in pragmatic outpatient pulmonary rehabilitation programmes. In this study we
explored whether metabolic stress occurs during incremental walking at the low work rates
these patients achieve.
Methods: Twenty-nine subjects with stable COPD [mean(SD) age 68(7) years, FEV1 50(19)%
predicted] performed maximal cardiopulmonary exercise tests on a cycle ergometer and
treadmill. Plasma ammonia concentration was measured at rest, 1 and 2 min of exercise, peak
exercise and 2 min recovery.
Results: Subjects achieved mean(SD) cycle work rate of 57(20) W with VO2max 15.5(4.6) ml/min
per kg, and treadmill distance 284(175) m with VO2peak 16.8(4.2) ml/min per kg. Plasma
ammonia concentration rose significantly (p < 0.001) with walking [mean(SEM) change
24.7(3.8) mmol/l] and cycling [mean(SEM) change 35.2(4.3) mmol/l], but peak exercise
ammonia was lower in walking (p < 0.01). In a subgroup of subjects (nZ 7) plasma ammonia
did not rise during either cycling or walking despite similar lactate rise and peak exercise
indices.
Conclusion: Our data indicate that failure of muscle ATP re-synthesis to meet demand and
development of metabolic stress can occur during walking in COPD patients at the low work
rates these patients achieve. This may therefore be a factor contributing to exercise limitation
independent of ventilatory limitation.
ª 2009 Elsevier Ltd. All rights reserved.of Respiratory Medicine, Peterborough District Hospital, Thorpe Road, Peterborough, PE3 6DA, UK.
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Exercise intolerance is a major factor limiting participation
in activities of daily living in people with chronic obstruc-
tive pulmonary disease (COPD) and patients commonly
complain of limited ability to perform walking exercise.
Pulmonary rehabilitation programmes aim to improve
exercise capacity, and in many centres walking is the most
frequent mode of exercise employed.
It is now appreciated that impaired lower limb skeletal
muscle function has a significant impact on exercise
capacity in patients with COPD.1 The energy for muscular
contraction is provided by the dephosphorylation of aden-
osine 5-triphosphate (ATP) to ADP. When ATP utilisation
during exercise cannot be matched by its re-synthesis, ATP
depletion occurs due to irreversible deamination to form
IMP and ammonia.2,3 This is associated with a rise in plasma
ammonia. These circumstances have been termed ‘meta-
bolic stress’ because of the detrimental impact on muscle
contraction4,5 and association with fatigue in healthy
subjects.4,5 The accumulation of ammonia in the blood can
be used as an indicator of ATP loss and the development of
metabolic stress in exercising skeletal muscle.2,6,7
Skeletal muscle ATP depletion8 and plasma ammonia
accumulation9 has been demonstrated during cycle exer-
cise in COPD patients. Data from the literature suggests
that the metabolic and physiological responses to walking
and cycling can differ significantly,10e13 and the degree to
which walking exercise imposes skeletal muscle metabolic
stress in COPD has not yet been established. However,
understanding the magnitude of ATP mismatch and meta-
bolic stress during walking may be important in making
decisions on exercise prescription, for example during PR,
in these patients.
In this study, plasma ammonia was used as a marker of
skeletal muscle ATP depletion and metabolic stress. We
hypothesised that metabolic stress would develop during
walking despite the low work rates these patients achieve.
In a cohort of COPD patients with significant exercise
limitation, we examined firstly whether plasma ammonia
accumulated during an incremental walking test, and
secondly whether walking provoked a similar peak response
to cycling.
In our previous work we observed, in a post hoc analysis,
a subgroup of patients who did not demonstrate a signifi-
cant rise in blood ammonia during cycling exercise despite
showing a rise in blood lactate. We hypothesised that there
would therefore be a subgroup of patients that would not
develop plasma ammonia accumulation with either walking
or cycling exercise tests.
Methods
Study population
Stable patients (nZ 29) who met GOLD criteria for COPD14
were recruited from the pulmonary rehabilitation waiting
list at Glenfield Hospital. Patients were excluded if taking
maintenance oral corticosteroids, had significant cardiac
dysfunction, or had undergone pulmonary rehabilitation
within the last 2 years. Full approval was obtained from theLeicestershire Research Ethics Committee and all partici-
pants provided informed written consent.
Study design
Subjects attended an initial visit for baseline measurements
[spirometry performed to ERS standards (Vitallograph Model
R, Buckingham, UK);15 body mass index] and familiarisation
tests on the cycle and treadmill. On a second visit at least
72 h later, subjects performed a maximal symptom-limited
incremental exercise test on an electrically-braked cycle
ergometer (Ergometric Er900; Ergoline GmbH, Bitz,
Germany) with increments of 10 W/min, using a ramp proto-
col. Subjects re-attended after a further 72 h or more to
perform a maximal symptom-limited treadmill exercise test
(RAM 770CE Treadmill; RAM Medical and Industrial Instru-
ments & Supplies, Padova, Italy). The incremental walking
protocol mirrored the ISWT (initial speed 1.8 km/h,
increasing every minute by 0.6 km/h, gradient 0) because
this field test is commonly used in clinical practice for
assessment of exercise ability and as an outcomemeasure in
pulmonary rehabilitation. Ventilation and gas exchange
measurements were made throughout the exercise tests
using a breath-by-breath computerised system (Zan-680
ErgoTest, Zan Messgeraete GmbH, Germany). End-exercise
Borg breathlessness score and reason for termination were
recorded.
Half an hour prior to the exercise test a 12 g retrograde
cannula was inserted into a superficial lower forearm vein
and placed inside a hand-warmer throughout exercise,
warmed to 50e55 C. Blood was sampled for ammonia and
lactate concentration during cycle and treadmill exercise
tests at rest, at 1 min and 2 min of exercise, at peak
exercise, and at 2 min after exercise cessation (recovery).
Timing for blood tests was determined from our previous
studies examining pattern of ammonia rise in COPD
patients.9 Whole blood lactate concentrations were
measured in duplicate immediately following exercise (YSI
1500 sport L-lactate analyser, YSI Inc, USA). Blood for
ammonia was centrifuged immediately, plasma stored at
196 C in liquid nitrogen, and analysed in duplicate by
a validated enzyme assay technique (SigmaeAldrich Co.
Ltd, UK) within 24 h as previously described.9
Data analysis
Using data from our previous study9 we required 22 patients
with an ammonia response to detect a 15 mmol/l within-
group difference in peak exercise blood ammonia between
the 2 exercise tests (80% power, pZ 0.05). Normality of
data was confirmed and significance was assumed at
p < 0.05. Paired t-tests were used to evaluate differences
between cycle and treadmill. Correlations between
parameters were calculated with Pearson’s correlation
tests (SPSS package version 15.0, SPSS Inc, Chicago, USA).
Subgroups were defined a priori by exercise-induced
ammonia rise with cycling above (group 1) or below (group
2) 15 mmol/l. This was based on the 95% limit of agreement
for resting variability of repeat measures of plasma
ammonia (unpublished data in healthy subjects) and on our
previous post hoc analyses in cycle exercise demonstrating
Incremental walking ammonia response in COPD 677these two subgroups.9 Between-group comparisons were
made using independent sample t-tests.
Results
Subject characteristics and exercise parameters
Twenty-nine subjects (21 male) with COPD completed the
study. Mean(SD) age was 68(7) years, FEV1 50(19)%
predicted and 1.27(0.50) l, and BMI 28(7) kg/m2. Twenty
subjects were ex-smokers and nine were current smokers.
All patients reported breathlessness on exertion [MRC
breathlessness score 5 (nZ 4), 4 (nZ 7), 3 (nZ 10) or 2
(nZ 8)].
Exercise data is shown in Table 1. In the cycle exercise
test, 11 subjects were deemed ventilatory limited [defined
as >90% maximum voluntary ventilation (FEV1  35)]. The
main cause of symptom limitation during cycling was either
dyspnoea (nZ 10) or leg fatigue (nZ 14). Two patients
complained of maximal effort and three of uncomfortable
mouthpiece. In the walking exercise test, 12 subjects were
deemed ventilatory limited. Main cause of symptom
limitation was dyspnoea (nZ 12) with fewer subjects
complaining of leg fatigue (nZ 8). Other causes were
maximal effort (nZ 4), speed (nZ 2) and uncomfortable
mouthpiece (nZ 3). There was no significant difference in
reason for stopping in ventilatory limited patients and
a similar number complained of dyspnoea or fatigue.
Ammonia and lactate response to exercise
Table 2 shows plasma ammonia and blood lactate responses
to cycle and treadmill exercise. In the COPD group as
a whole, there was a significant (p < 0.001) plasma
ammonia and blood lactate rise with both cycling and
treadmill walking. The pattern of plasma ammonia andTable 1 Exercise data for incremental cycle and walking
exercise in COPD subjects (nZ 29).
Cycling Walking
Peak workload (W) 57 (20) e
Distance (m) e 284 (175)
Exercise time (s) 353 (141) 310 (124)
VO2max (ml/min per kg) 15.52 (4.56) 16.83 (4.16)
*
VEmax (l/min) 35.2 (11.0) 36.0 (9.8)
VEmax (% MVV) 84 (23) 86 (20)
Heart rate (% predicted) 73 (11) 72 (9)
Peak oxygen
saturation (%)
93 (4) 91 (5)**
Peak RER 0.96 (0.05) 0.89 (0.06)**
Peak BSa 4 (3e5) 4 (4e7)
Peak PEa 15 (14e17) 15 (13e17)
Data expressed as mean (SD) unless stated. VO2max, maximum
oxygen uptake; VEmax, maximum ventilation; MVV, maximum
voluntary ventilation (calculated as FEV1  35); peak RER, peak
respiratory quotient; peak BS, breathlessness measured by Borg
score at peak exercise; peak PE, perceived exertion at peak
exercise. *pZ 0.019; **p < 0.001.
a Median (IQR).blood lactate rise was similar for both exercise modalities,
although peak exercise concentrations were statistically
lower in treadmill walking (p < 0.01) (Fig. 1). The rise in
ammonia concentration correlated with peak work on cycle
(rZ 0.66, p < 0.001) and distance on treadmill (rZ 0.43,
pZ 0.02). There was correlation between cycle and
treadmill tests in ammonia rise (rZ 0.61, p < 0.001) and
lactate rise (rZ 0.74, p < 0.001). There were no differ-
ences between patients who did or did not reach ventila-
tion limitation in peak exercise indices, or ammonia and
lactate responses for both cycling and walking.
Subgroup analysis
Subjects who displayed an ammonia response to cycle
exercise (group 1, nZ 22) had a consistent response in
treadmill walking except in three cases where exercise-
induced ammonia change was below 15 mmol/l with
walking. All 3 patients had BMI over 40 and one had exercise
desaturation to 80% in walking but not cycling. All subjects
without an ammonia rise with cycling (group 2, nZ 7)
similarly did not have a response with walking (Fig. 2). In
group 2 peak work was significantly lower for cycling and
walking distance was lower without reaching statistical
significance. ISWT distance was significantly lower. There
were no other significant differences in any measured
demographic variable, medication, exercise parameter,
ventilatory limitation or exercise-induced lactate rise
between the 2 subgroups (Table 3). In group 1, 12 patients
stopped cycling due to fatigue and 7 due to dyspnoea,
compared with 2 and 3 patients respectively in group 2.
During walking, 7 patients stopped due to fatigue and 10
patients due to dyspnoea in group 1, compared with 1 and 2
respectively in group 2.
Subgroup comparison of the ammonia and lactate
response to exercise is shown in Fig. 3. The mean(SEM)
ammonia rise from resting values in group 1 was
45.3(3.4) mmol/l (cycle) and 31.9(3.9) mmol/l (treadmill).
In group 2 ammonia change with exercise was
3.5(1.3) mmol/l (bike) and 2.3(2.3) mmol/l (treadmill).
Blood lactate accumulation with exercise was not signifi-
cantly different between group 1 and group 2 for cycling
[mean(SEM) 1.51(0.15) mmol/l and 1.17(0.22) mmol/l,
pZ 0.24], or walking [mean(SEM) 0.94(0.18) mmol/l and
0.70(0.12) mmol/l respectively, pZ 0.47].
Discussion
In this study, we explored the plasma ammonia response to
a maximal incremental walking exercise test, which
mirrored the ISWT used in PR, in a cohort of patients with
COPD. We observed a rise in plasma ammonia despite the
low work rates these individuals achieved. These results
suggest that muscle ATP depletion and metabolic stress
occur during walking and may be a factor contributing to
exercise limitation in patients with COPD. However, there
was a subgroup of patients who did not have an ammonia
rise during walking, and in whom a similar response was
seen with cycling.
Metabolic stress develops in exercising skeletal muscle
when ATP re-synthesis fails to meet demand, and the















Cycle 52.6 (14.6) 62.3 (17.9)* 68.7 (18.6)* 84.0 (23.5)* 79.6 (23.3)* 35.2 (4.27)*




Cycle 0.73 (0.15) 0.90 (0.21)* 1.01 (0.26)* 1.91 (0.67)* 2.07 (0.76)* 1.43 (0.12)*
Treadmill 0.71 (0.19) 0.81 (0.26)* 0.92 (0.32)* 1.39 (0.68)*,y 1.54 (0.81)*,y 0.88 (0.14)*,y
Mean (SD) values unless stated. *p < 0.001 within-group, compared with resting value. yp < 0.001, yyp < 0.01 between group cycle vs
treadmill analysis.
a Mean (SEM).
678 L.D. Calvert et al.accumulation of ammonia in the blood has been widely
used as an indicator of this.2,6,7 In COPD patients, although
there is evidence of altered skeletal muscle oxidative
energy metabolism,16,17 it has been unclear whether suffi-
cient exercise work rates can be achieved to cause signifi-
cant metabolic stress, particularly in patients with
evidence of a ventilatory limit to exercise. We have
recently confirmed that adenine nucleotide loss and plasma
ammonia accumulation does occur during cycle exercise in
COPD patients and that its magnitude was comparable toFigure 1 Mean(SE) change from resting concentration for
plasma ammonia (mmol/l) (A) and blood lactate (mmol/l) (B)
during incremental exercise in COPD subjects (nZ 29) with
cycling (closed square) and treadmill walking (closed triangle).
*p < 0.01, **p < 0.001, between cycle and treadmill analysis.that observed in similar-aged healthy subjects despite
substantially lower absolute work rates in COPD patients.8,9
Walking is more functionally relevant to patients than
cycling and understanding the magnitude of metabolic
stress during walking may therefore be more clinically
relevant. However, there are important differences
between metabolic responses to walking and cycling and
our previous findings may not be transferable. In the
current study, significant ATP loss as indicated by a rise in
plasma ammonia did occur during walking exercise, but at
a lower magnitude to that seen during cycling. These
findings suggest that the imbalance between ATP demand
and re-synthesis and the consequent development of
metabolic stress is occurring during incremental walking in
these patients. There was little difference in ammonia
response between patients defined as ventilatory limited
and non-ventilatory limited, suggesting that metabolic
stress develops in the ambulatory muscles even in patients
with an apparent ventilatory limit to exercise.Figure 2 Scatter to show exercise-induced change in
ammonia concentration for individual subjects (nZ 29) ach-
ieved in cycling and treadmill exercise. The dotted line
represents the threshold for definition of a significant ammonia
response (see Methods section for more detail).
Table 3 Baseline characteristics and exercise parameters
for COPD subjects with an ammonia response to cycle
exercise (group 1, nZ 22) and without an ammonia





Age (years) 68 (6) 69 (10)
FEV1 (% predicted) 50 (19) 52 (19)
FVC 2.56 (0.73) 2.39 (0.79)
FEV/FVC (%) 50 (11) 51 (10)
BMI 28 (6) 29 (9)
FFMI (kg/m2) 18 (2) 19 (3)
Oxygen saturation at
rest (%)
96 (2) 96 (1)
ISWT distance (m) 307 (121) 183 (118)**
ESWT distance (s) 176 (55) 151 (48)
Cycle
VO2max(ml/min per kg) 16.1 (4.8) 13.6 (3.3)
Peak workload (W) 61 (20) 43 (14)*
Peak VEmax (% MVV) 86 (22) 78 (28)
Heart rate (% predicted) 73 (11) 76 (10)
Lactate rise (mmol/l) 1.51 (0.15) 1.17 (0.22)
Treadmill
VO2max (ml/min per kg) 17.0 (4.4) 16.4 (3.5)
Distance (m) 309 (184) 205 (123)
Time (s) 329 (124) 248 (109)
VEmax (% MVV) 85 (21) 89 (21)
Heart rate (% predicted) 72 (10) 74 (6)
Lactate rise (mmol/l) 0.94 (0.18) 0.70 (0.12)
Data expressed as mean (SD). FEV1, forced expiratory volume in
1 s; FVC, forced vital capacity; BMI, body mass index; FFMI, fat
free mass index; VO2peak, peak oxygen uptake; VEmax, maximum
ventilation; MVV, maximum voluntary ventilation (calculated as
FEV1  35); ISWT, incremental shuttle walk test; ESWT, endur-
ance shuttle walk test. *pZ 0.043; **pZ 0.025.
Incremental walking ammonia response in COPD 679There are a number of studies in the literature
comparing ventilatory and metabolic responses to walking
and cycling, but not metabolic stress. Whilst Palange and
others have reported higher ventilatory demand and
increased gas exchange inefficiency with walking,10e12,18
Troosters found no difference in VO2peak and blood gases
between the two exercise modailities.19 Some of these
differences are likely to be due to different exercise
protocols used. However, a consistent finding is lower blood
lactate rise and less contractile fatigue13 with walking,
suggesting reduced metabolic response. Our results
indicate that whilst important ventilatory and metabolic
differences exist, both exercise modalities can lead to
metabolic stress.
Whilst we observed a similar overall pattern of lactate
and ammonia accumulation during exercise in walking and
cycling, we reproduced our previous observation of disso-
ciation of the ammonia and lactate response in some
patients.9 In other words, some subjects did not demon-
strate a blood ammonia rise during exercise despite
showing a rise in blood lactate. This was broadly consistent
between the two exercise platforms. The reasons for these
differences cannot be determined from our data. One
possibility is that patients without an ammonia responsewere unable to exercise to sufficient intensity to cause ATP
loss. In support of this hypothesis, there was a trend
towards lower exercise capacity and lactate accumulation
in this group, although this was not statistically significant
and larger sample size may be necessary to investigate this
further. These individuals may have terminated exercise for
other reasons such as motivation. Although we did not
observe significantly higher peak ventilation rates or lower
oxygen saturations in this group and the proportion of
patients with ventilation limitation were similar between
the two groups, we have not measured other ventilatory
indices such as dynamic hyperinflation. Alternatively, this
group may have had better preserved mitochondrial func-
tion or type I fibre proportions than those who did
demonstrate a rise in ammonia. This would result in more
efficient adenine nucleotide rephosphorylation and there-
fore less deamination and reduced ammonia production.5
Previous literature on COPD has suggested a shift in fibre
composition towards a greater proportion of type II fibres
although significant variability is present.20,21 The prepon-
derance of type II fibres may explain the rise in ammonia at
low absolute work rates in the overall COPD cohort whereas
conversely, the absence of an ammonia rise may identify
patients in whom type I fibres are better preserved. It is
possible that this subgroup may respond differently to
interventions targeting skeletal muscles. However, the
clinical implications of the differential ammonia response
are yet to be determined.
Ability to perform walking exercise is an important
concern for many patients with COPD and is commonly
applied in pragmatic outpatient pulmonary rehabilitation
programmes. In this study, plasma ammonia rise occurred
during walking in many individuals with COPD despite low
work intensities. This is in contrast to studies in healthy
subjects where ammonia accumulation is only seen at high
exercise intensities,6,7,22 and suggests that ATP depletion
may be a more frequent occurrence in COPD compared with
healthy subjects. It is conceivable therefore from our
results that normal activities of daily living and the regular
high intensity walking exercise entailed in pulmonary
rehabilitation represent repeated bouts of skeletal muscle
metabolic stress for some COPD patients. Since the adenine
nucleotide deamination pathway is a potential source of
exercise-induced oxidative stress through the activity of
xanthine oxidase,23 it is possible that regular metabolic
stress is a trigger for free radical production which may
have an impact on wider cellular function. This may be an
important consideration influencing exercise prescription
and impacting physiological adaption in pulmonary
rehabilitation.
We acknowledge limitations to the interpretation of our
data. To avoid the need for muscle biopsy immediately
post-exercise (a technically challenging and invasive
procedure), we did not measure adenine nucleotide loss
directly, relying on the less invasive measurement of
plasma ammonia. However, numerous previous investiga-
tions in healthy subjects have confirmed the relationship
between AMP deamination and plasma ammonia accumu-
lation3,4,22,24 and we have also demonstrated this in COPD
patients.9 Although a control group has not been used, the
ammonia response to incremental cycling and walking is
extensively documented in healthy subjects and the aim of
Figure 3 Mean(SE) change from resting concentration for plasma ammonia (mmol/l) (A,B) and blood lactate (mmol/l) (C,D)
during incremental cycling and treadmill walking exercise in COPD subjects with an ammonia response (group 1, closed square,
nZ 22), and COPD subjects without an ammonia response (group 2, closed triangle, nZ 7). *p < 0.001, **pZ 0.055, between
group 1 and group 2 analysis.
680 L.D. Calvert et al.this study was to determine whether metabolic stress was
occurring in walking rather than making any comparison
with response in healthy subjects. Our observations are
limited to maximal incremental exercise performance and
may not be transferable to endurance exercise. The ISWT
was used in this study as it is a common clinical assessment
tool and pulmonary rehabilitation outcome measure and
exercise is prescribed from this measure. Sample size is
small and further studies are required to fully evaluate the
clinical usefulness of ammonia determination during exer-
cise in COPD patients.
In summary, we have demonstrated that plasma
ammonia concentration increases significantly during
incremental treadmill walking in many subjects with COPD.
Although the pattern of response was similar to cycling, the
magnitude of rise was lower with walking. Our data indicate
that failure of muscle ATP re-synthesis to meet demand and
development of metabolic stress can occur during walking
in this population, and this may therefore be a factor
contributing to exercise limitation independent of ventila-
tory limitation to exercise.
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